Scientific Programme Thursday 2 September 2021

 
THURSDAY 2 SEPTEMBER
Time/Society  ESVC abstracts

 SCH abstracts

ESVIM/ISCAID abstracts

 

EDUCATION STREAM 
09.00-09.40

 

 

Stefan Unterer (DE)
What is the real role of bacteria in acute and chronic diarrhoea?

MASTERCLASS
Ian Ramsey (UK)
Interpretation of endocrine tests

09.45-10.25    

Nicola Decaro (I)
What is the real role of (new and old) viruses in canine gastrointestinal disease?

10.30-11.15

BREAK

11.20-12.00    

Dieter Barutzki (DE)
What is the real role of gastrointestinal protozoal infections – to treat or not to treat?

MASTERCLASS
Laureen Peters (CH)
Cytology for internists and oncologists

 
12.05-12.45

Philippe Pibarot (CA)
SOTA: Guidelines for assessment and treatment of MMVD in humans part I

 

Manuela Schnyder (CH)
Gastrontestinal helmintic infections and drug resistence – testing or treating?

12.50-14.20

BREAK

13.20-14.15 Cardiology Diplomate meeting   SCH AGM ESVIM AGM   
Time/Society   ESVC

SCH 

 

ESVIM/ISCAID

 RESEARCH REPORTS

14.25-15.05

Philippe Pibarot (CA)
SOTA: Guidelines for assessment and treatment of MMVD in humans part II

 JAN ROTHUIZEN AWARD for best abstract

Stuart Forbes (UK)
How does the damaged liver regenerate?

 

Katarina Hazuchova (DE)
Feline diabetes mellitus - can we blame the genes?

15.10-15.50

Mark Rishniw (USA)
Guidelines for classification and treatment of MMVD – a critical review

 Stuart Forbes (UK)
Macrophage therapy for liver cirrhosis- from bench to trial
 

Joana Aguiar (UK)
Unravelling the pathogenesis of feline hyperthyroidism

15.55-16.25  BREAK
16.30-17.10 P Pibarot, J Häggström, M Rishniw, A Boswood, D Adin, M Schneider
Panel discussion: Staging of dogs with  MMVD
 Hedwig Kruitwagen (NL)
Hepatic organoids from dogs and cats: expanding the toolbox
 

Hannah Sargent (UK)
Phosphate homeostasis in early feline CKD

17.15-17.55

Patricia Pesavento (USA)
Novel hepadnavirus in cats

 

Shira Burg (IL)
Targeting SK4 K+ channels with small allosteric modulators as a novel treatment for atrial fibrillation and cardiac fibrosis

18.00 ECVIM-CA AGM